Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases.
about
Histone deacetylase inhibitors as novel anticancer therapeutics.Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis.Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor.Sulforaphane restores acetyl-histone H3 binding to Bcl-2 promoter and prevents apoptosis in ethanol-exposed neural crest cells and mouse embryos.
P2860
Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological inhibition of ...... ers and inflammatory diseases.
@en
type
label
Pharmacological inhibition of ...... ers and inflammatory diseases.
@en
prefLabel
Pharmacological inhibition of ...... ers and inflammatory diseases.
@en
P2093
P2860
P1476
Pharmacological inhibition of ...... ers and inflammatory diseases.
@en
P2093
Claire Bonfils
Donald R Walkinshaw
Jeffrey M Besterman
Xiang-Jiao Yang
P2860
P304
P356
10.1517/17460441.3.9.1041
P407
P577
2008-09-01T00:00:00Z